Your browser does not support JavaScript! LAXATIVE MAXIMUM STRENGTH (SENNOSIDES) TABLET [EQUALINE (SUPERVALU)]
DailyMed Logo Header image

Daily Med

Current Medication Information

Options

RxNorm Names

LAXATIVE MAXIMUM STRENGTH (sennosides) tablet
[EQUALINE (SuperValu)]


Category DEA Schedule Marketing Status
HUMAN OTC DRUG LABEL OTC monograph not final
NOTE:MOST OTC DRUGS ARE NOT REVIEWED AND APPROVED BY FDA, HOWEVER THEY MAY BE MARKETED IF THEY COMPLY WITH APPLICABLE REGULATIONS AND POLICIES. FDA HAS NOT EVALUATED WHETHER THIS PRODUCT COMPLIES.
Drug Label Sections

DRUG FACTS

Active ingredient (in each tablet)

Sennosides USP, 25 mg

Purpose

Stimulant laxative

Uses

  • relief of occasional constipation (irregularity). This product generally produces bowel movement within 6 to 12 hours.

Warnings

Do not use

  • when abdominal pain, nausea, or vomiting are present
  • for longer than 1 week, unless directed by a doctor

Ask a doctor before use if

  •  you notice a sudden change in bowel habits that persists over a period of 2 weeks

Stop use and ask a doctor if

  • you have rectal bleeding
  • you fail to have a bowel movement after use.

These may be signs of a serious condition.

If pregnant or breast-feeding,

 ask a health care professional before use.

Keep out of reach of children

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  adults and children 12 years of age and older take 2 tablets once or twice daily with a glass of water
  children 6 to under 12 years of age  take 1 tablet once or twice daily with a glass of water
  children under 6 years of ageconsult a doctor

Other information

  • each tablet contains: calcium 40 mg/ tablet
  • each tablet contains: magnesium 10 mg/ tablet
  • each tablet contains: sodium 3 mg/ tablet VERY LOW SODIUM 
  • store at 15º - 30º C (59º-86º F)
  • keep in a dry place
  • do not expose to excessive heat

Inactive ingredients

acacia, anhydrous lactose*, calcium sulfate anhydrous, carnauba wax, colloidal silicon dioxide, corn starch, croscarmellose sodium, dibasic calcium phosphate dihydrate, FD&C Blue #1 Aluminum Lake, iron oxide, iron oxide Black, iron oxide Yellow, isopropyl alcohol*, kaolin, lake brilliant blue FCF*, magnesium stearate, maltodextrin*, microcrystalline cellulose, Opacode black S-1-17823*, opagloss 6000P*, polyethylene glycol, povidone, pregelatinized starch, shellac, sodium lauryl sulfate, stearic acid, sugar, talc, tartaric acid*, titanium dioxide.

*contains one or more of these ingredients

Questions or Comments?

Call toll free 1-877-932-7948

Principal Display Panel

Compare to maximum strength EX-LAX® active ingredient †

Maximum Strength

Laxative

Sennosides USP, 25 mg

stimulant laxative

dependable overnight relief

TAMPER EVIDENT- USE ONLY IF BLISTERS ARE INTACT

KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION

This product is not manufactured or distributed by Novartis Consumer Health, Inc., owner of the registered trademark Ex-Lax®

Product Label

Equaline Laxative maximum strength

Sennosides 25 mg

LAXATIVE  MAXIMUM STRENGTH
sennosides tablet
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:41163-139
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (SENNOSIDES) SENNOSIDES25 mg
Inactive Ingredients
Ingredient NameStrength
ACACIA 
CALCIUM SULFATE ANHYDROUS 
CARNAUBA WAX 
SILICON DIOXIDE 
STARCH, CORN 
CROSCARMELLOSE SODIUM 
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE 
FD&C BLUE NO. 1 
FERRIC OXIDE RED 
FERROSOFERRIC OXIDE 
FERRIC OXIDE YELLOW 
KAOLIN 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
POLYETHYLENE GLYCOLS 
POVIDONES 
SHELLAC 
SODIUM LAURYL SULFATE 
STEARIC ACID 
SUCROSE 
TALC 
TITANIUM DIOXIDE 
ANHYDROUS LACTOSE 
ISOPROPYL ALCOHOL 
MALTODEXTRIN 
TARTARIC ACID 
Product Characteristics
ColorBLUEScoreno score
ShapeROUNDSize10mm
FlavorImprint Code TCL083;S25
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41163-139-484 in 1 CARTON
112 in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart33408/23/2010
Labeler - EQUALINE (SuperValu) (006961411)
Registrant - P and L Development of New York Corporation (800014821)

Revised: 4/2013
 
EQUALINE (SuperValu)

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services